This HTML5 document contains 46 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n17http://linked.opendata.cz/ontology/domain/vavai/riv/typAkce/
dctermshttp://purl.org/dc/terms/
n10http://localhost/temp/predkladatel/
n5http://purl.org/net/nknouf/ns/bibtex#
n15http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n11http://linked.opendata.cz/ontology/domain/vavai/
n7http://linked.opendata.cz/resource/domain/vavai/zamer/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n6http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n19http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n4http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F62157124%3A16170%2F03%3A00000382%21RIV06-MSM-16170___/
n18http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n14http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n20http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n16http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n13http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F62157124%3A16170%2F03%3A00000382%21RIV06-MSM-16170___
rdf:type
n11:Vysledek skos:Concept
dcterms:description
The goal of the study is to emphasise clinically significant properties of medetomidine - opioids combinations. Total of 90 dogs were included to the study, in which various painful procedures had been performed. Dogs were divided into three groups. In the FEN group medetomidine 0.01 mg/kg (n=30) had been given with fentanyl 0.01 mg/kg bolus following by 0.01 mg/kg/hr infusion. The BUT group (n=30) presented combination of medetomidin 0.01 mg/kg with butorphanol 0.2 mg/kg bolus only. The BUP group (n=30) had been given medetomidine 0.01 mg/kg with buprenorphine 0.01 mg/kg. All combinations were used as a bolus mixed in one syringe. Anesthesia induction had been facilitate by propofol administration and then maintained by O<sub>2<sub>/N<sub>2<sub>O/halothane inhalation. Insufficient depth of anesthesia was solved by propofol readministration. As main criteria, the level of sedation, initiative dose of propofol, as well as the need of its readministration had been observed. Furth Cílem studie bylo zhodnotit klinicky významné účinky kombinace medetomidinu s opioidy - s butorfanolem, buprenorfinem nebo fentanylem. Hodnocenými kritérii byla úroveň sedace po premedikaci, množství propofolu pro indukci a dávka inhalačních anestetik pro vedení anestezie a změna vitálních parametrů v průběhu anestezie. nejlepší sedaci navozovala kombinace s fentanylem, při níž bylo zároveň potřebné i nejmenší množství propofolu pro indukci. The goal of the study is to emphasise clinically significant properties of medetomidine - opioids combinations. Total of 90 dogs were included to the study, in which various painful procedures had been performed. Dogs were divided into three groups. In the FEN group medetomidine 0.01 mg/kg (n=30) had been given with fentanyl 0.01 mg/kg bolus following by 0.01 mg/kg/hr infusion. The BUT group (n=30) presented combination of medetomidin 0.01 mg/kg with butorphanol 0.2 mg/kg bolus only. The BUP group (n=30) had been given medetomidine 0.01 mg/kg with buprenorphine 0.01 mg/kg. All combinations were used as a bolus mixed in one syringe. Anesthesia induction had been facilitate by propofol administration and then maintained by O<sub>2<sub>/N<sub>2<sub>O/halothane inhalation. Insufficient depth of anesthesia was solved by propofol readministration. As main criteria, the level of sedation, initiative dose of propofol, as well as the need of its readministration had been observed. Furth
dcterms:title
Clinical evaluation of medetomidine-opioid agonists, -partial agonists and -mixed agonist/antagonists combination for anesthesia premedication in the dog Clinical evaluation of medetomidine-opioid agonists, -partial agonists and -mixed agonist/antagonists combination for anesthesia premedication in the dog Klinické zhodnocení kombinace medetomidinu-opioidního agonisty, -parciálního agonisty a agonisty/antagonisty pro premedikaci celkové anestezie u psů
skos:prefLabel
Clinical evaluation of medetomidine-opioid agonists, -partial agonists and -mixed agonist/antagonists combination for anesthesia premedication in the dog Klinické zhodnocení kombinace medetomidinu-opioidního agonisty, -parciálního agonisty a agonisty/antagonisty pro premedikaci celkové anestezie u psů Clinical evaluation of medetomidine-opioid agonists, -partial agonists and -mixed agonist/antagonists combination for anesthesia premedication in the dog
skos:notation
RIV/62157124:16170/03:00000382!RIV06-MSM-16170___
n3:strany
138
n3:aktivita
n18:Z
n3:aktivity
Z(MSM 161700002)
n3:dodaniDat
n13:2006
n3:domaciTvurceVysledku
n15:1257447 n15:2819546
n3:druhVysledku
n16:D
n3:duvernostUdaju
n19:S
n3:entitaPredkladatele
n4:predkladatel
n3:idSjednocenehoVysledku
601376
n3:idVysledku
RIV/62157124:16170/03:00000382
n3:jazykVysledku
n14:eng
n3:klicovaSlova
alpha-2 agonist; opioid
n3:klicoveSlovo
n6:alpha-2%20agonist n6:opioid
n3:kontrolniKodProRIV
[B2F8528D81BB]
n3:mistoKonaniAkce
Knoxville, Tennessee, USA
n3:mistoVydani
Knoxville, Tennessee, USA
n3:nazevZdroje
8th World Congress of Veterinary Anesthesia
n3:obor
n20:FP
n3:pocetDomacichTvurcuVysledku
2
n3:pocetTvurcuVysledku
4
n3:rokUplatneniVysledku
n13:2003
n3:tvurceVysledku
Sootornvipart, Kumpanart Lexmaulová, Leona Vlašín, Michal Raušer, Petr
n3:typAkce
n17:WRD
n3:zahajeniAkce
2003-09-16+02:00
n3:zamer
n7:MSM%20161700002
s:issn
5400-5166
s:numberOfPages
1
n5:hasPublisher
University of Tennessee
n10:organizacniJednotka
16170